(Q73337534)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9150246%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9150246%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

P Nègre-Aminou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9150246%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A K van Vliet

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9150246%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M van Erck

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9150246%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

G C van Thiel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9150246%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R E van Leeuwen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9150246%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

L H Cohen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9150246%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 April 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9150246%20AND%20SRC:MED&resulttype=core&format=json

Biochimica et Biophysica Acta

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9150246%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

1345

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9150246%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9150246%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

259-268

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9150246%20AND%20SRC:MED&resulttype=core&format=json

CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side chain ester derivatives of mevinolin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

Long-term efficacy with fluvastatin as monotherapy and combined with cholestyramine (a 156-week multicenter study). French-Dutch Fluvastatin Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

Intimal injury in vivo activates vascular smooth muscle cell migration and explant outgrowth in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

Prevention of restenosis by lovastatin after successful coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

Essential role for mevalonate synthesis in DNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

Protein isoprenylation and methylation at carboxyl-terminal cysteine residues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

Different effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on sterol synthesis in various human cell types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

Action of lovastatin, simvastatin, and pravastatin on sterol synthesis and their antiproliferative effect in cultured myoblasts from human striated muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

A quantitative technique for growing human adult skeletal muscle in culture starting from mononucleated cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in human hepatoma cell line Hep G2. Effects of inhibitors of cholesterol synthesis on enzyme activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

The MTT assay underestimates the growth inhibitory effects of interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further pitfall in the use of the MTT assay for evaluating cell growth and survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

Inhibition of human vascular smooth muscle cell proliferation by lovastatin: the role of isoprenoid intermediates of cholesterol synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

Effects of a competitive inhibitor (mevinolin) of 3-hydroxy-3-methylglutaryl coenzyme A reductase on human and bovine endothelial cells, fibroblasts and smooth muscle cells in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

Cell cycle-specific effects of lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

PKC activity in rat C6 glioma cells: changes associated with cell cycle and simvastatin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2896%2900184-1

10.1016/S0005-2760(96)00184-1

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9150246%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference